Pediatrix Medical Group, Inc. (MD) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
MD Revenue Growth
Revenue Breakdown (FY 2025)
MD's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
MD Revenue Analysis (2014–2025)
As of May 8, 2026, Pediatrix Medical Group, Inc. (MD) generated trailing twelve-month (TTM) revenue of $1.93 billion, reflecting modest growth of +3.9% year-over-year. The most recent quarter (Q1 2026) recorded $476.2 million in revenue, down 3.6% sequentially.
Looking at the longer-term picture, MD's 5-year compound annual growth rate (CAGR) stands at +2.0%, indicating moderate growth over time. The company achieved its highest annual revenue of $3.65 billion in 2018.
Revenue diversification analysis shows MD's business is primarily driven by Health Care, Patient Service (85%), Hospitals Contracts (14%), and Product and Service, Other (1%). With over half of revenue concentrated in Health Care, Patient Service, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including THC (+4.6% YoY), NKTR (-43.9% YoY), and AMSF (+7.8% YoY), MD has underperformed the peer group in terms of revenue growth. Compare MD vs THC →
MD Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| MDCurrent | $1.9B | +3.9% | +2.0% | 12.1% | |
 THC | $21.3B | +4.6% | +3.9% | 16.1% | |
 NKTR | $55M | -43.9% | -18.4% | -236.8% | |
 AMSF | $317M | +7.8% | -1.3% | 18.6% | |
 HCA | $75.6B | +7.1% | +8.0% | 15.8% | |
 UHS | $17.4B | +10.4% | +8.5% | 11.5% |
MD Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $1.91B | -4.9% | $471.9M | 24.7% | $231.1M | 12.1% |
| 2024 | $2.01B | +0.9% | $454.3M | 22.6% | $-68,713,000 | -3.4% |
| 2023 | $1.99B | +1.1% | $421.6M | 21.1% | $7.3M | 0.4% |
| 2022 | $1.97B | +3.2% | $467.0M | 23.7% | $172.7M | 8.8% |
| 2021 | $1.91B | +10.2% | $513.2M | 26.9% | $202.9M | 10.6% |
| 2020 | $1.73B | -2.6% | $449.3M | 25.9% | $98.1M | 5.7% |
| 2019 | $1.78B | -51.2% | $503.1M | 28.3% | $171.8M | 9.7% |
| 2018 | $3.65B | +5.5% | $989.5M | 27.1% | $445.8M | 12.2% |
| 2017 | $3.46B | +8.6% | $1.00B | 28.9% | $480.1M | 13.9% |
| 2016 | $3.18B | +14.5% | $1.03B | 32.5% | $571.7M | 18.0% |
See MD's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs MD Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare MD vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonMD — Frequently Asked Questions
Quick answers to the most common questions about buying MD stock.
Is MD's revenue growth accelerating or slowing?
MD revenue growth slowed to +3.9%, below the 5-year CAGR of +2.0%. TTM revenue is $1.9B. The deceleration marks a shift from historical growth rates.
What is MD's long-term revenue growth rate?
Pediatrix Medical Group, Inc.'s 5-year revenue CAGR of +2.0% reflects the variable expansion pattern. Current YoY growth of +3.9% is near this long-term average.
How is MD's revenue distributed by segment?
MD reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.